{"id":929193,"date":"2026-01-21T08:23:46","date_gmt":"2026-01-21T13:23:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/"},"modified":"2026-01-21T08:23:46","modified_gmt":"2026-01-21T13:23:46","slug":"notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/","title":{"rendered":"Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf"},"content":{"rendered":"
\n

PHILADELPHIA, Jan. 21, 2026 (GLOBE NEWSWIRE) — <\/p>\n

\n
\n Ibotta, Inc. (NYSE: IBTA):<\/u>
\n <\/strong>\n <\/p>\n

Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.<\/p>\n

\n If you purchased Ibotta, Inc. shares on or shortly after the company\u2019s April 18<\/strong>
\n , 2024 IPO,<\/strong>
\n and still hold shares today, <\/strong>
\n you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/ibotta-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085, to learn more.<\/strong><\/p>\n

WHY?<\/strong> A federal securities fraud class action complaint alleges that statements made in Ibotta Inc\u2019s (NYSE: IBTA) Registration Statement issued in connection with Ibotta\u2019s April 18, 2024 initial public offering were false and\/or misleading when made because they did not properly warn investors of the risks concerning Ibotta\u2019s contract with The Kroger Co. Kroger\u2019s contract was at-will, and Ibotta failed to warn investors that a large client could cancel their contract with Ibotta without warning. Despite providing a detailed explanation of the terms of Ibotta\u2019s contract with Walmart, there was not a single warning of the at-will nature of Kroger\u2019s contract.<\/p>\n

\n WHAT YOU CAN DO NOW:<\/strong>
\n If you purchased Ibotta, Inc. (NYSE: IBTA) shares on or shortly after the company\u2019s April 18<\/strong>
\n , 2024 IPO,<\/strong>
\n and still hold shares today, <\/strong>
\n you are encouraged to visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/ibotta-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.<\/strong>\u00a0\u00a0 $IBTA #IBTA #Ibotta<\/p>\n

\n
\n Integer Holdings Corp.\u00a0(NYSE: ITGR):<\/u>
\n <\/strong>\n <\/p>\n

Grabar Law Office is investigating claims on behalf of shareholders of Integer Holdings Corp.\u00a0(NYSE: ITGR). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.<\/p>\n

\n If you purchased<\/strong>
\n Integer Holdings Corp. (NYSE: ITGR)<\/strong>
\n , <\/strong>
\n shares prior to July 25, 2024<\/strong>
\n , <\/strong>
\n and still hold shares today, <\/strong>
\n you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. You are encouraged to visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/integer-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085. <\/strong>
\n \n <\/p>\n

\n WHY?<\/strong> As alleged in a recently filed federal securities fraud class action complaint, Integer Holdings Corp.\u00a0(NYSE: ITGR), through certain of its officers, made materially false and\/or misleading and failed to disclose material adverse facts about the Company\u2019s business, operations, and prospects. Specifically, it is alleged that the Company failed to disclose that: (1) Integer materially overstated its competitive position within the growing EP manufacturing market; (2) despite Integer\u2019s claims of strong visibility into customer demand, the Company was experiencing a sustained deterioration in sales relating to two of its EP devices; (3) in turn, Integer mischaracterized its EP devices as a long-term growth driver for the Company\u2019s C&V segment; and (4) as a result of the above, Defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially false and misleading and\/or lacked a reasonable basis at all relevant times.<\/p>\n

\n WHAT YOU CAN DO NOW:<\/strong>
\n If you purchased<\/strong>
\n Integer Holdings Corp. (NYSE: ITGR)<\/strong>
\n , <\/strong>
\n shares prior to July 25, 2024<\/strong>
\n , <\/strong>
\n and still hold shares today, <\/strong>
\n you are encouraged to visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/integer-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.<\/strong> #ITGR $ITGR #IntegerHoldings<\/p>\n

\n
\n Lifecore Biomedical, Inc. (NASDAQ: LFCR)<\/u>
\n <\/strong>
\n
\n – Securities Fraud Class Action Reaches Settlement:<\/u>
\n <\/strong>\n <\/p>\n

Grabar Law Office is investigating claims on behalf of shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR) as a securities fraud class action has now reached a settlement<\/strong>. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.<\/p>\n

Current Lifecore Biomedical, Inc. (NASDAQ: LFCR) who have held shares since before October 7, 2020, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. You are encouraged to visit https:\/\/grabarlaw.com\/the-latest\/lifecore-shareholder-investigation\/<\/a>, contact Joshua Grabar at jgrabar@grabarlaw.com<\/a>, or call 267-507-6085. <\/p>\n

WHY?<\/strong>A recently filed federal securities class action against Lifecore Biomedical, Inc. (NASDAQ: LFCR) and certain of its officers <\/strong>has reached a settlement<\/u><\/strong>.\u00a0 \u00a0The underlying class action Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, the Complaint alleges Defendants made false and\/or misleading statements and\/or failed to disclose that: (i) Lifecore maintained deficient internal controls over financial reporting; (ii) as a result, the Company issued several financial statements that were inaccurate and would need to be restated; (iii) Lifecore’s purported remediation efforts with respect to the foregoing deficiencies were ineffective; (iv) all of the foregoing impaired Lifecore’s ability to timely file periodic reports with the SEC in compliance with NASDAQ listing requirements; (v) accordingly, the Company’s financial position and\/or prospects were materially overstated; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.<\/p>\n

Lifecore and individual defendants have entered into an agreement in principle with the plaintiffs to settle the class action.<\/strong><\/p>\n

\n WHAT YOU CAN DO NOW:<\/strong>
\n If you purchased<\/strong>
\n Lifecore Biomedical, Inc. (NASDAQ: LFCR)<\/strong>
\n shares prior to <\/strong>
\n October 7, 2020,<\/strong>
\n and still hold shares today, <\/strong>
\n you are encouraged to visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/lifecore-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.<\/strong>
\n
#LFCR $LFCR #Lifecore<\/p>\n

\n
\n Molina Healthcare, Inc. <\/u>
\n <\/strong>
\n
\n (NYSE: MOH)<\/u>
\n <\/strong>
\n :<\/strong>\n <\/p>\n

Grabar Law Office is investigating claims on behalf of shareholders of Molina Healthcare, Inc. (NYSE: MOH). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.<\/p>\n

\n If you purchased <\/strong>
\n Molina Healthcare, Inc. <\/strong>
\n (NYSE: MOH)<\/strong>
\n , <\/strong>
\n shares prior to <\/strong>
\n February 5, 2025<\/strong>
\n and still hold shares today, <\/strong>
\n you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/molina-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085 to learn more. <\/strong>\n <\/p>\n

\n WHY?<\/strong> As alleged in an underlying securities fraud class action complaint, Molina Healthcare, Inc. (NYSE: MOH), through certain of its officers, failed to disclose: (1) material, adverse facts concerning Molina Healthcare’s “medical cost trend assumptions”; (2) that Molina Healthcare was experiencing a “dislocation between premium rates and medical cost trend”; (3) that Molina Healthcare’s near term growth was dependent on a lack of “utilization of behavioral health, pharmacy, and inpatient and outpatient services”; and (4) as a result, Molina Healthcare’s financial guidance for fiscal year 2025 was substantially likely to be cut.<\/p>\n

\n WHAT YOU CAN DO NOW:<\/strong>
\n If you purchased <\/strong>
\n Molina Healthcare, Inc. <\/strong>
\n (NYSE: MOH)<\/strong>
\n , <\/strong>
\n shares prior to <\/strong>
\n February 5, 2025<\/strong>
\n and still hold shares today, <\/strong>
\n you are encouraged to visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/molina-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.<\/strong>\u00a0\u00a0 $MOH #Molina #MOH<\/p>\n

\n Attorney Advertising Disclaimer<\/a>\n <\/p>\n

Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: \u00a0267-507-6085
Email: jgrabar@grabarlaw.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

PHILADELPHIA, Jan. 21, 2026 (GLOBE NEWSWIRE) — Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased Ibotta, Inc. shares on or shortly after the company\u2019s April 18 , 2024 IPO, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https:\/\/grabarlaw.com\/the-latest\/ibotta-shareholder-investigation\/ , contact Joshua Grabar at jgrabar@grabarlaw.com , or call 267-507-6085, to learn more. WHY? A federal securities fraud class action complaint alleges that statements made in Ibotta … <\/p>\n

Continue reading “Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-929193","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNotice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, Jan. 21, 2026 (GLOBE NEWSWIRE) — Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased Ibotta, Inc. shares on or shortly after the company\u2019s April 18 , 2024 IPO, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https:\/\/grabarlaw.com\/the-latest\/ibotta-shareholder-investigation\/ , contact Joshua Grabar at jgrabar@grabarlaw.com , or call 267-507-6085, to learn more. WHY? A federal securities fraud class action complaint alleges that statements made in Ibotta … Continue reading "Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-21T13:23:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyOTY2MiM3MzcyODQxIzIyMDEyNzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf\",\"datePublished\":\"2026-01-21T13:23:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\\\/\"},\"wordCount\":1286,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyOTY2MiM3MzcyODQxIzIyMDEyNzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\\\/\",\"name\":\"Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyOTY2MiM3MzcyODQxIzIyMDEyNzA=\",\"datePublished\":\"2026-01-21T13:23:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyOTY2MiM3MzcyODQxIzIyMDEyNzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyOTY2MiM3MzcyODQxIzIyMDEyNzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/","og_locale":"en_US","og_type":"article","og_title":"Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf - Market Newsdesk","og_description":"PHILADELPHIA, Jan. 21, 2026 (GLOBE NEWSWIRE) — Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased Ibotta, Inc. shares on or shortly after the company\u2019s April 18 , 2024 IPO, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https:\/\/grabarlaw.com\/the-latest\/ibotta-shareholder-investigation\/ , contact Joshua Grabar at jgrabar@grabarlaw.com , or call 267-507-6085, to learn more. WHY? A federal securities fraud class action complaint alleges that statements made in Ibotta … Continue reading \"Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-21T13:23:46+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyOTY2MiM3MzcyODQxIzIyMDEyNzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf","datePublished":"2026-01-21T13:23:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/"},"wordCount":1286,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyOTY2MiM3MzcyODQxIzIyMDEyNzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/","name":"Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyOTY2MiM3MzcyODQxIzIyMDEyNzA=","datePublished":"2026-01-21T13:23:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyOTY2MiM3MzcyODQxIzIyMDEyNzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyOTY2MiM3MzcyODQxIzIyMDEyNzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-shareholders-of-ibotta-inc-nyse-ibta-integer-holdings-corp-nyse-itgr-lifecore-biomedical-inc-nasdaq-lfcr-and-molina-healthcare-inc-nyse-moh-grabar-law-office\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/929193","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=929193"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/929193\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=929193"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=929193"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=929193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}